Tuesday, January 10, 2017
Medical Marijuna, Inc. Investment AXIM(R) Biotech Receives Positive PK Data Results for CanChew Plus(R) CBD Gum
AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing Gum SAN DIEGO, CA AXIM, (Marketwired) Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech)(OTC: AXIM) has received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials with patients suffering from irritable bowel
http://bit.ly/2jf7gXH
Subscribe to:
Post Comments (Atom)
Story sounds good
ReplyDelete